Paratek Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 701-725 of 958 matching filings.

Per page
25
Current page
29
8-K File 000-51967

FORM 8-K

Filing date
13 Sep 2013
Reporting date
13 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Sep 2013
Reporting date
11 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Sep 2013
Reporting date
06 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
05 Sep 2013
Reporting date
02 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-81821

SCHEDULE 13D 9-4-13

Filing date
05 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

SCHEDULE 13D/A

Filing date
29 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-81821

SCHEDULE 13D

Filing date
14 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
07 Aug 2013
Reporting date
07 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81821

SCHEDULE 13G

Filing date
02 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - OCLASSEN

Filing date
18 Jul 2013
Reporting date
15 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - SOLOWAY

Filing date
18 Jul 2013
Reporting date
15 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - SINGH

Filing date
18 Jul 2013
Reporting date
15 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - KOLLINS

Filing date
18 Jul 2013
Reporting date
15 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - PATTERSON

Filing date
18 Jul 2013
Reporting date
15 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
18 Jul 2013
Reporting date
18 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81821

TRANSCEPT SCHEDULE 13G/A 6-27-13

Filing date
27 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
04 Jun 2013
Reporting date
04 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
13 May 2013
Reporting date
13 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-51967

FORM 8-K/A

Filing date
09 May 2013
Reporting date
09 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
08 May 2013
Reporting date
08 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

8-K

Filing date
08 May 2013
Reporting date
08 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-188171

EFFECT filing

Filing date
06 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-188171

S-3

Filing date
26 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .